Pharma Mar Statistics

Total Valuation

Pharma Mar has a market cap or net worth of EUR 1.38 billion. The enterprise value is 1.29 billion.

Market Cap	1.38B
Enterprise Value	1.29B

Important Dates

The next estimated earnings date is Friday, February 28, 2025.

Earnings Date	Feb 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Pharma Mar has 17.54 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	17.54M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	11.79%
Owned by Institutions (%)	6.70%
Float	12.71M

Valuation Ratios

The trailing PE ratio is 2,213.51 and the forward PE ratio is 35.70. Pharma Mar's PEG ratio is 0.33.

PE Ratio	2,213.51
Forward PE	35.70
PS Ratio	8.24
PB Ratio	7.56
P/TBV Ratio	7.61
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	0.33

Financial Ratio History

Enterprise Valuation

EV / Earnings	2,067.34
EV / Sales	7.70
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-72.78

Financial Position

The company has a current ratio of 2.66, with a Debt / Equity ratio of 0.29.

Current Ratio	2.66
Quick Ratio	1.99
Debt / Equity	0.29
Debt / EBITDA	34.15
Debt / FCF	-3.03
Interest Coverage	-1.47

Financial Efficiency

Return on equity (ROE) is 0.32% and return on invested capital (ROIC) is -0.91%.

Return on Equity (ROE)	0.32%
Return on Assets (ROA)	-0.65%
Return on Capital (ROIC)	-0.91%
Revenue Per Employee	328,100
Profits Per Employee	1,222
Employee Count	509
Asset Turnover	0.49
Inventory Turnover	0.23

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +79.47% in the last 52 weeks. The beta is 0.20, so Pharma Mar's price volatility has been lower than the market average.

Beta (5Y)	0.20
52-Week Price Change	+79.47%
50-Day Moving Average	74.83
200-Day Moving Average	46.01
Relative Strength Index (RSI)	54.37
Average Volume (20 Days)	67,067

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pharma Mar had revenue of EUR 167.00 million and earned 622,000 in profits. Earnings per share was 0.03.

Revenue	167.00M
Gross Profit	157.68M
Operating Income	-3.54M
Pretax Income	-4.03M
Net Income	622,000
EBITDA	-477,000
EBIT	-3.54M
Earnings Per Share (EPS)	0.03

Full Income Statement

Balance Sheet

The company has 144.39 million in cash and 53.48 million in debt, giving a net cash position of 90.92 million or 5.18 per share.

Cash & Cash Equivalents	144.39M
Total Debt	53.48M
Net Cash	90.92M
Net Cash Per Share	5.18
Equity (Book Value)	182.17M
Book Value Per Share	10.39
Working Capital	148.58M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.65 million and capital expenditures -19.32 million, giving a free cash flow of -17.67 million.

Operating Cash Flow	1.65M
Capital Expenditures	-19.32M
Free Cash Flow	-17.67M
FCF Per Share	-1.01

Full Cash Flow Statement

Margins

Gross margin is 94.42%, with operating and profit margins of -2.12% and 0.37%.

Gross Margin	94.42%
Operating Margin	-2.12%
Pretax Margin	-2.41%
Profit Margin	0.37%
EBITDA Margin	-0.29%
EBIT Margin	-2.12%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.65, which amounts to a dividend yield of 0.83%.

Dividend Per Share	0.65
Dividend Yield	0.83%
Dividend Growth (YoY)	23.46%
Years of Dividend Growth	n/a
Payout Ratio	1,836.01%
Buyback Yield	n/a
Shareholder Yield	0.83%
Earnings Yield	0.04%
FCF Yield	-1.28%

Dividend Details

Stock Splits

The last stock split was on July 22, 2020. It was a reverse split with a ratio of 0.0833333333.

Last Split Date	Jul 22, 2020
Split Type	Reverse
Split Ratio	0.0833333333

Scores

Pharma Mar has an Altman Z-Score of 4.17.

Altman Z-Score	4.17
Piotroski F-Score	n/a